Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based studyDunya Tomic, Dianna J. Magliano, Edward W. Gregg et al.|The Lancet Diabetes & Endocrinology|2022Cited by 72
Targeting Diabetes Prevention to More Disadvantaged Groups Improves Cost-Effectiveness: Implications of Inequality in Type 2 Diabetes From Theoretical InterventionsJedidiah I Morton, Zanfina Ademi|Value in Health|2023Cited by 5